News

Bio International Convention

Bill Milgram (President and CEO) and Joseph Araujo (Vice President and CFO) will be attending this year's Bio International Convention in Chicago. If you will be attending the Convention or are in the area and would like to set up a meeting, please do not hesitate to contact either Bill (1-416-677-6140) or Joseph (1-416-677-6085).

International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters

CanCog is a proud sponsor of this year's International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters. Dr. Guy Higgins will be attending the meeting and presenting results from studies we have conducted on NOS inhibitors. To learn more about the capabilities of CanCog in evaluating your NCE please contact Dr. Higgins at 416- 716-5504.

International Conference on Alzheimer's Disease 2010

CanCog will be attending the Alzheimer's Association International Conference on Alzheimer's Disease from July 10-15 in Honolulu, Hawaii. Be sure to watch the conference video featuring CanCog VP/CFO, Joseph Araujo. Please visit us at booth 908.

2010 Epilepsy Pipeline Update

Dr. Howard Dobson, DVM, will be presenting during the Early Stage and Marketed Devices, Hybrids session on Day 1, February 25, 9:15-11:15 AM, at the 2010 Epilepsy Pipeline Update Conference . If you would like to learn more about CanCog's capabilities, please contact Dr. Dobson at 1-519-400-6053.

Neuroscience 2009

CanCog will be attending Neuroscience 2009 from Oct. 17-21, in Chicago. If you are attending, please visit us at booth #707.

BioContact 2009

Joseph Araujo, VP/CFO of CanCog Technologies will be presenting at the BioContact Quebec 2009 symposium, on Wednesday, Oct. 7 ^th at 3:30pm.

14th Annual Meeting of Canine Cognition & Aging

This is a yearly meeting focused specifically on advancing the canine model of human cognitive aging. This year's meeting provided several new and unexpected findings that advanced the model considerably and raised new questions for the direction of therapeutics in Alzheimer's disease. Visit the conference web site for more information.

Alzheimer's Association International Conference on Alzheimer's Disease 2009

CanCog will be attending the Alzheimer's Association International Conference on Alzheimer's Disease from July 11-16 in Vienna, Austria. If you are attending, please visit us at booth #314.

Neuroscience 2008

CanCog will be attending Neuroscience 2008 from November 15-18 in Washington, D.C. If you are attending, please visit us at booth #2635.

Alzheimer's Association International Conference on Alzheimer's Disease 2008

CanCog will be attending the Alzheimer's Association International Conference on Alzheimer's Disease from July 26-31 in Chicago. If you are attending, please visit us at booth #619.

Federation of European Neuroscience Societies 2008

CanCog will be attending the Federation of European Neuroscience Societies from July 12-16 in Geneva. If you are attending, please visit us at booth 119.

13th Annual Meeting of Canine Cognition & Aging

CanCog is proud to sponsor the The 13th Annual Canine Cognition, Aging and Neuropathology Conference . The conference will be held June 5-7, 2007 in Toronto, Canada. Registration is now open.

Neuroscience 2006

CanCog personnel will be attending Neuroscience 2006, from October 14th to October 18th. Please come visit us at booth #2338.

12th Annual Meeting of Canine Cognition & Aging

This is a yearly meeting focused specifically on advancing the canine model of human cognitive aging. This year's meeting provided several new and unexpected findings that advanced the model considerably and raised new questions for the direction of therapeutics in Alzheimer's disease.

Slowing of age-dependent cognitive decline in the dog by a combination of antioxidant enriched food and behavioral enrichment.

The January 2005 issue of the Neurobiology of Aging has just published findings authored by N.W. Milgram, et al. indicating that age-dependent cognitive decline can be slowed by an intervention that combines dietary enrichment and behavioral enrichment. A synopsis was published on Tuesday, Jan 25th by the New York Times.

Proceedings of the 10th annual canine cognition and aging meeting to be published by Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The proceedings of the 10th annual canine cognition and aging meeting will be published this Winter by Progress in Neuro-Psychopharmacology and Biological Psychiatry . Issue details are available.

10th Annual Canine Cognition and Aging and Conference

The 10th annual Canine Cognition and Aging and Conference has been scheduled for June 14th and 15th, 2004, at St. Michael's College in downtown Toronto, Canada. The meeting will cover an overview of 10 years of research, achievements and potential directions. Conference registration information is now available.

Canine neuropsychological tests successfully applied in down's syndrome research

Down's syndrome adults have an exceptionally high risk of developing Alzheimer's disease. Unfortunately, their cognitive capabilities are difficult to assess because of impaired communication skills. To address this issue, Dr. Linda Nelson of the University of California at Irvine has modified tests developed to assess canine cognitive aging, thus providing a nonverbal protocol for assessing cognitive function. On June 30th, at the 9th annual canine cognition meeting, Dr. Nelson reported that Down's syndrome patients are highly motivated to perform the tasks, and show age-dependent decline in object memory tasks. By contrast, object discrimination learning was acquired rapidly, and did not show age differences. These results parallel age-dependent changes in dogs and further validate the canine model of cognitive aging.

Impaired mitochondrial function is linked to canine brain aging and is partially reversible by antioxidants

Mitochondria are organelles that supply cells with energy, but in doing so also produce reactive oxygen species (ROS). These molecules can damage other intracellular compounds, leading cellular dysfunction,. Dr. At the 9th annual Canine Cognition Meeting, Dr. Patrick Sullivan of the University of Kentucky reported, impaired mitochondrial function in aged dogs. He found that mitochondrial production of ROS was significantly increased in aged dogs, when compared to young. These data indicate compromised mitochondiral bioenergetics as a function of age. However, the effect can be partly attenuated by selective dietary supplementation. Significant improvement in mitochondrial function, when compared to controls, was found in a group of aged dogs maintained on a specially formulated food enriched in antioxidants and mitochondrial cofactors for over two years.

Antioxidant diet reduces brain pathology in aged beagles

Elizabeth Head and collaborators studied beta amyloid pathology in aged beagle dogs that were maintained for over two years on either control food or food enriched with antioxidants and mitochondrial cofactors. The animals maintained on the high antioxidant diet showed less beta amyloid accumulation in three different brain regions: the parietal lobes, the entorhinal cortex, and the occipital cortex. These findings indicate that oxidative stress has a causal role in the development of beta amyloid pathology, and that this development is slowed by nutritional supplementation.

9th Annual Canine Cognition, Aging and Neuropathology Conference, Laguna Beach, CA

Meeting of experts in the fields of canine health, behavior, and neuroscience will be held to discuss current and future research projects.

CanCog Technologies hires Dr. David Stevens as Executive Chairman of the Board

We are pleased to announce that Dave Stevens, DVM Ph.D.,has agreed to join CanCog Technologies Inc. in the capacity of Executive Chairman of the Board. Dr. Stevens brings essential experience in both the human and animal pharmaceutical industry, having previously served as CEO of Deprenyl Animal Health, which developed Anipryl, the first FDA sanctioned drug for an AD-like disease in geriatric dogs.